Zurich Cantonal Bank Portfolio holdings
AUM
$40.9B
1-Year Return
22.88%
This Quarter Return
+14.1%
1 Year Return
+22.88%
3 Year Return
+106.76%
5 Year Return
+189.8%
10 Year Return
+428.78%
AUM
$40.9B
AUM Growth
+$6.08B
(+17%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
33.91%
Holding
2,675
New
37
Increased
1,264
Reduced
635
Closed
96
Top Buys
| 1 |
AMRZ
Amrize Ltd
AMRZ
|
$452M |
| 2 |
NVIDIA
NVDA
|
$177M |
| 3 |
Apple
AAPL
|
$170M |
| 4 |
Microsoft
MSFT
|
$170M |
| 5 |
UBS Group
UBS
|
$134M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$112M |
| 2 |
CME Group
CME
|
$93.4M |
| 3 |
Procter & Gamble
PG
|
$65.5M |
| 4 |
Walt Disney
DIS
|
$60.1M |
| 5 |
Verizon
VZ
|
$53.2M |
Sector Composition
| 1 | Technology | 31.19% |
| 2 | Financials | 17.34% |
| 3 | Healthcare | 10.5% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JKS
2426
JinkoSolar
JKS
$1.31B
| $15K | ﹤0.01% |
709
-63
| -8% | -$1.34K |
|
2427
British American Tobacco
BTI
$122B
| $14.7K | ﹤0.01% |
311
| – | – |
|
2428
American Public Education
APEI
$568M
| $14.7K | ﹤0.01% |
481
+142
| +42% | +$4.33K |
|
2429
Ascendis Pharma
ASND
$12.4B
| $14.3K | ﹤0.01% |
83
-14
| -14% | -$2.42K |
|
2430
Trevi Therapeutics
TRVI
$867M
| $14.1K | ﹤0.01% |
2,576
-305
| -11% | -$1.67K |
|
2431
Mesa Laboratories
MLAB
$356M
| $13.9K | ﹤0.01% |
148
| – | – |
|
2432
Tevogen Bio Holdings
TVGN
$171M
| $13.8K | ﹤0.01% |
11,013
-1,181
| -10% | -$1.48K |
|
2433
Theravance Biopharma
TBPH
$716M
| $13.7K | ﹤0.01% |
1,246
-136
| -10% | -$1.5K |
|
2434
Hyster-Yale Materials Handling
HY
$667M
| $13.4K | ﹤0.01% |
336
| – | – |
|
2435
Summit Therapeutics
SMMT
$19B
| $13.4K | ﹤0.01% |
628
-108
| -15% | -$2.3K |
|
2436
AbCellera Biologics
ABCL
$1.24B
| $13K | ﹤0.01% |
3,789
-416
| -10% | -$1.43K |
|
2437
Rigel Pharmaceuticals
RIGL
$729M
| $12.4K | ﹤0.01% |
663
-73
| -10% | -$1.37K |
|
|
DQ
2438
Daqo New Energy
DQ
$1.95B
| $12.2K | ﹤0.01% |
805
-70
| -8% | -$1.06K |
|
2439
MeiraGTx Holdings
MGTX
$618M
| $12K | ﹤0.01% |
1,841
-204
| -10% | -$1.33K |
|
2440
Pacific Biosciences
PACB
$378M
| $12K | ﹤0.01% |
9,672
-74,657
| -89% | -$92.6K |
|
2441
Personalis
PSNL
$459M
| $12K | ﹤0.01% |
1,827
-203
| -10% | -$1.33K |
|
2442
Zevra Therapeutics
ZVRA
$499M
| $11.6K | ﹤0.01% |
1,319
-145
| -10% | -$1.28K |
|
|
LENZ
2443
LENZ Therapeutics
LENZ
$1.15B
| $11.6K | ﹤0.01% |
396
-64
| -14% | -$1.88K |
|
2444
Regenxbio
RGNX
$498M
| $11.5K | ﹤0.01% |
1,397
-156
| -10% | -$1.28K |
|
2445
Galapagos
GLPG
$2.18B
| $11.4K | ﹤0.01% |
409
-46
| -10% | -$1.29K |
|
2446
Inhibrx
INBX
$402M
| $10.5K | ﹤0.01% |
737
-87
| -11% | -$1.24K |
|
2447
AstraZeneca
AZN
$253B
| $10.5K | ﹤0.01% |
150
| – | – |
|
2448
argenx
ARGX
$45.8B
| $10.5K | ﹤0.01% |
19
-2
| -10% | -$1.1K |
|
2449
GlobalFoundries
GFS
$18.4B
| $10.2K | ﹤0.01% |
266
-76
| -22% | -$2.9K |
|
2450
Limoneira
LMNR
$287M
| $9.28K | ﹤0.01% |
593
+22
| +4% | +$344 |
|